Cartesian Therapeutics (RNAC)
NASDAQ:RNAC
Holding RNAC?
Track your performance easily

Cartesian Therapeutics (RNAC) Technical Analysis

1,092 Followers

Technical Sentiment

Overall Consensus
Buy
13Bullish
6Neutral
3Bearish
Technical Analysis Consensus
Neutral
2Bullish
6Neutral
2Bearish
Moving Average Consensus
Strong Buy
11Bullish
0Neutral
1Bearish
Cartesian Therapeutics’s (RNAC) Moving Averages Convergence Divergence (MACD) indicator is 0.25, suggesting Cartesian Therapeutics is a Buy.
Cartesian Therapeutics’s (RNAC) 20-Day exponential moving average is 20.68, while Cartesian Therapeutics’s (RNAC) share price is $20.86, making it a Buy.
Cartesian Therapeutics’s (RNAC) 50-Day exponential moving average is 19.56, while Cartesian Therapeutics’s (RNAC) share price is $20.86, making it a Buy.

Cartesian Therapeutics (RNAC) Pivot Points

Nov 10, 2024, 05:41 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
17.82
18.43
19.12
19.73
20.42
21.03
21.71
Fibonacci
18.43
18.93
19.23
19.73
20.23
20.53
21.03
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Cartesian Therapeutics (RNAC) Moving Averages

Nov 10, 2024, 05:41 AM
Period
Simple
Exponential
MA5
19.85Buy
20.29Buy
MA10
20.77Buy
20.62Buy
MA20
21.33Sell
20.68Buy
MA50
18.60Buy
19.56Buy
MA100
17.96Buy
19.42Buy
MA200
20.21Buy
20.78Buy
Cartesian Therapeutics’s (RNAC) 10-Day exponential moving average is 20.62, while Cartesian Therapeutics’s (RNAC) share price is $20.86, making it a Buy.
Cartesian Therapeutics’s (RNAC) 100-Day exponential moving average is 19.42, while Cartesian Therapeutics’s (RNAC) share price is $20.86, making it a Buy.
Cartesian Therapeutics’s (RNAC) stock price is $20.86 and Cartesian Therapeutics’s (RNAC) 50-day simple moving average is 18.60, creating a Buy signal.
Cartesian Therapeutics’s (RNAC) stock price is $20.86 and Cartesian Therapeutics’s (RNAC) 100-day simple moving average is 17.96, creating a Buy signal.
Cartesian Therapeutics’s (RNAC) stock price is $20.86 and Cartesian Therapeutics’s (RNAC) 200-day simple moving average is 20.21, creating a Buy signal.

Cartesian Therapeutics (RNAC) Technical Indicators

Nov 10, 2024, 05:41 AM
Name
Value
Implied Action
RSI (14)
51.99
Neutral
STOCH (9,6)
23.78
Neutral
STOCHRSI (14)
22.94
Neutral
MACD (12,26)
0.25
Buy
ADX (14)
22.74
Neutral
Williams %R
-57.03
Buy
CCI (14)
-54.95
Neutral
ATR (14)
1.83
-
Ultimate Oscillator
43.88
Neutral
ROC
-3.87
Sell
Cartesian Therapeutics’s (RNAC) Relative Strength Index (RSI) is 51.99, creating a Neutral signal.
Cartesian Therapeutics’s (RNAC) Trend Strength Indicator (ADX) is 22.74, creating a Neutral signal.
Cartesian Therapeutics’s (RNAC) Commodity Channel Index (CCI) is -54.95, creating a Neutral signal.
Cartesian Therapeutics’s (RNAC) Price Rate of Change (ROC) is -3.87, creating a Sell signal.

FAQ

Is RNAC a Buy, Hold, or Sell?
Based on RNAC’s technical indicators, RNAC is a Buy.
    What is RNAC’s RSI (14)?
    RNAC’s RSI (14) is 51.99, which suggests RNAC is a Neutral.
      What is RNAC’s MACD?
      RNAC’s MACD is 0.25, which suggests RNAC is a Buy.
        What is RNAC’s 5-day moving average?
        RNAC’s 5-day moving average is 19.85, which suggests RNAC is a Buy.
          What is RNAC’s 20-day moving average?
          RNAC 20-day moving average is 21.33, which suggests RNAC is a Sell.
            What is RNAC’s 50-day moving average?
            RNAC’s 50-day moving average is 18.60, which suggests RNAC is a Buy.
              What is RNAC’s 200-day moving average?
              RNAC’s 200-day moving average is 20.21, which suggests RNAC is a Buy.
                What is RNAC’s Williams % R (14)?
                RNAC’s Williams % R (14) is -57.03, which suggests RNAC is a Buy.
                  What is RNAC’s CCI (14)?
                  RNAC’s CCI (14) is -54.95, which suggests RNAC is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis